Loading organizations...

§ Private Profile · Magdeburg, Germany
neotiv is a technology company.
neotiv has raised $11.2M across 2 funding rounds.
Key people at neotiv.
neotiv has raised $11.2M in total across 2 funding rounds.
Neotiv develops a digital platform featuring unique cognitive tests for early medical assessment and longitudinal follow-up of memory problems, particularly in Alzheimer's disease. It offers intuitive visual memory tasks for tracking performance, alongside customizable health questionnaires and neuropsychological evaluations. This flexible architecture supports research and healthcare applications, facilitating study configurations via a web portal and mobile app.
Co-founded by Dr. David Berron, Prof. Dr. med. Emrah Düzel, and Dr. Chris Rehse, neotiv leverages expertise in neuroscience, medicine, and technology. Their insight was to integrate rigorous cognitive testing with digital innovation. This foundation allows for accessible, precise methods to monitor memory health, advancing dementia research and improving patient care.
Neotiv's solutions support researchers in study designs and healthcare professionals for diagnosis and drug development. Globally utilized, the platform is validated by scientists for accuracy. The company envisions advancing Alzheimer's research and delivering patient-centered digital health solutions, aiming for seamless integration into medical procedures for safe, effective patient experiences.
Key people at neotiv.
neotiv has raised $11.2M across 2 funding rounds. Most recently, it raised $10.2M Series A Extension in November 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 11, 2022 | $10.2M Series A Plus | Capricorn Venture Partners | BMP Ventures, Convergence Partners, High Tech Grunderfonds, RSJ Investments, Sana Future, Vega Ventures | Announced |
| Oct 1, 2022 | $1M Seed | — | Autism Impact Fund, Endeavor Venture Funds, Wakeup Capital | Announced |
neotiv has raised $11.2M in total across 2 funding rounds.
neotiv's investors include Capricorn Venture Partners, bmp Ventures, Convergence Partners, High-Tech Grunderfonds, RSJ Investments, Sana Future, Vega Ventures, Autism Impact Fund, Endeavor Venture Funds, WakeUp Capital.
Neotiv is a German digital‑health company that builds CE‑marked digital cognitive assessment tools and a cloud platform to screen for and monitor early memory impairment, primarily to detect and track Alzheimer’s‑related cognitive change in healthcare and research settings[5][1].
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick reiteration: neotiv is a science‑driven German digital‑health company (founded 2017) that builds CE‑marked, remote cognitive assessment apps and a cloud platform to enable earlier detection and monitoring of Alzheimer’s‑related cognitive decline, and has progressed from academic spin‑out to commercial and research adoption supported by institutional funding and consortium partnerships[5][1][2].[5]
If you’d like, I can:- Summarize neotiv’s product features and study evidence in a one‑page brief; or- Map their partnerships and competitors in digital cognitive assessment and Alzheimer’s biomarkers.